You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 72888-0050


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 72888-0050

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

72888-0050 Market Analysis and Financial Projection

Market Analysis and Price Projections for Metoprolol Tartrate (NDC: 72888-005)

Introduction to Metoprolol Tartrate

Metoprolol tartrate, identified by the NDC code 72888-005, is a film-coated oral tablet used primarily for the treatment of hypertension, angina pectoris, and certain heart-related conditions. It is classified as a beta-adrenergic blocker and is distributed by Advagen Pharma Limited[1][5].

Current Market Status

Generic Competition

Metoprolol tartrate is a generic drug, which means it faces significant competition from other generic manufacturers. The generic nature of the drug typically leads to lower prices due to market competition. However, the pricing can still be influenced by various factors such as production costs, regulatory environment, and market demand.

Pricing Trends

In the pharmaceutical industry, pricing trends are often influenced by broader market dynamics. For instance, Vizient, Inc. has projected a 3.81% overall drug price inflation rate for 2025, which could impact the pricing of generic drugs like metoprolol tartrate, although the effect may be less pronounced compared to branded or specialty drugs[2].

Price Projections

General Inflation Impact

Given the projected 3.81% drug price inflation rate for 2025, it is likely that the price of metoprolol tartrate could see a modest increase. However, this increase would be relatively small compared to other pharmaceutical products, especially those with newer or more complex formulations.

Generic Market Dynamics

The generic market is highly competitive, which generally keeps prices stable or slightly increasing over time. The price stability is also influenced by the presence of multiple manufacturers, which helps in maintaining competitive pricing.

Regulatory and Market Factors

Regulatory changes, such as shifts in FDA policies or changes in healthcare reimbursement models, can also impact the pricing of generic drugs. However, these factors are typically more significant for branded or innovative drugs rather than established generics like metoprolol tartrate.

Market Analysis

Demand and Supply

The demand for metoprolol tartrate remains steady due to its widespread use in managing cardiovascular conditions. The supply side is well-established with multiple manufacturers, ensuring that the drug is readily available.

Competitive Landscape

The competitive landscape for metoprolol tartrate is characterized by numerous generic manufacturers. This competition helps in keeping the prices competitive and stable. Advagen Pharma Limited, the labeler of NDC 72888-005, operates within this competitive environment.

Future Trends

Technological and Data Trends

While technological advancements, such as the use of artificial intelligence (AI) in pharmaceutical development, are becoming more prevalent, they are less likely to directly impact the pricing of established generic drugs like metoprolol tartrate. However, these trends can influence the broader pharmaceutical market and indirectly affect pricing strategies[3].

Healthcare Policy and Reimbursement

Changes in healthcare policies and reimbursement models can significantly impact drug pricing. For generic drugs, these changes might lead to adjustments in pricing but are generally less dramatic compared to branded or specialty medications.

Key Takeaways

  • Price Stability: The price of metoprolol tartrate is expected to remain relatively stable due to its generic status and competitive market.
  • Modest Inflation: A modest price increase, aligned with the projected 3.81% drug price inflation rate, is likely.
  • Regulatory and Market Factors: Any significant changes in regulatory policies or market dynamics could influence pricing, but these are less likely to have a major impact on established generics.
  • Technological Trends: While AI and other technological advancements are shaping the pharmaceutical industry, they are less likely to directly affect the pricing of metoprolol tartrate.

FAQs

Q: What is the primary use of metoprolol tartrate? A: Metoprolol tartrate is primarily used for the treatment of hypertension, angina pectoris, and certain heart-related conditions.

Q: Who is the distributor of metoprolol tartrate with NDC 72888-005? A: The distributor is Advagen Pharma Limited.

Q: What is the projected drug price inflation rate for 2025? A: The projected drug price inflation rate for 2025 is 3.81% according to Vizient, Inc.[2].

Q: How does the generic status of metoprolol tartrate affect its pricing? A: The generic status generally keeps the prices competitive and stable due to market competition.

Q: Are there any significant technological trends that could impact the pricing of metoprolol tartrate? A: While technological advancements are shaping the pharmaceutical industry, they are less likely to directly impact the pricing of established generic drugs like metoprolol tartrate.

Sources

  1. FDA Report: NDC 72888-005 Oral Tablet, Film Coated Metoprolol Tartrate Drug.
  2. Vizient Inc.: Vizient projects drug price inflation at 3.81%.
  3. Intelligencia.ai: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch.
  4. GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  5. DailyMed: METOPROLOL TARTRATE tablet, film coated.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.